Key Record Dates
ClinicalTrials.gov Identifier: | NCT05680922 |
---|---|
Brief Title: | DLL3-Directed Chimeric Antigen Receptor T-cells in Subjects With Extensive Stage Small Cell Lung Cancer |
First Submitted : | December 21, 2022 |
First Submitted that Met QC Criteria : | January 10, 2023 |
First Posted : | January 11, 2023 |
Last Update Submitted that Met QC Criteria : | February 8, 2024 |
Last Update Posted : | February 9, 2024 |